Literature DB >> 3123495

Purification and characterization of cytochrome P-450-dependent arachidonic acid epoxygenase from human liver.

M Laniado-Schwartzman1, K L Davis, J C McGiff, R D Levere, N G Abraham.   

Abstract

A novel human liver cytochrome P-450 isozyme (P-450-AA), which catalyzes arachidonic acid epoxidation, has been purified to electrophoretic homogeneity from human liver. As judged spectrally, the newly described isozyme is low spin in the oxidized state, with a soret band at 415 nm and an increased maximum at 451 nm in the CO-difference spectrum. Cytochrome P-450-AA appeared homogeneous as judged by the appearance of a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an estimated molecular weight of 53,100. Although cytochrome P-450-AA had a relatively low specific content of 10.8 nmol/mg, it possessed a high activity of arachidonic acid epoxidation. The P-450-AA oxidized arachidonic acid in a reconstituted system into the four regioisomeric epoxyeicosatrienoic acids (EETs) (5, 6-, 8, 9-, 11, 12-, 14, 15-EETs) at a rate of 2,010 pmol/nmol/min, a rate which is 37-fold higher than that observed with the crude microsomal preparation. Moreover, the purified cytochrome P-450-AA catalyzed the de-ethylation of 7-ethoxyresorufin at the rate of 2970 pmol/nmol/min, whereas other cytochrome P-450-dependent reactions were carried out at 23-2,000-fold lower rates and ranged between 0.3-130 pmol/nmol/min. The amino acid composition is different from that of other cytochrome P-450 isozymes. The NH2-terminal sequence of 20-amino acid residues was compared to that of LM2 and PB2-B2, the phenobarbital-induced forms in rabbit and rats, respectively. Comparison was also made with two forms of human cytochrome P-450, HLc and HLd. There were 7/20 identical residues for P-450-AA and LM2 and 4/20 for P-450-AA and PB2-B2. There were 2/20 identical residues for P-450-AA and HLd, and no identical residues were found for HLc. We conclude that the biologically active EETs, are formed by a distinct and unique P-450 isozyme from human liver and that arachidonic acid can serve as a screen for detection of the novel P-450 isozyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  The eicosanoids and their biochemical mechanisms of action.

Authors:  W L Smith
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

2.  Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.

Authors:  F Catella; J A Lawson; D J Fitzgerald; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 3.  Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450.

Authors:  E H Oliw; J Bylund; C Herman
Journal:  Lipids       Date:  1996-10       Impact factor: 1.880

4.  A regiospecific monooxygenase with novel stereopreference is the major pathway for arachidonic acid oxygenation in isolated epidermal cells.

Authors:  M J Holtzman; J Turk; A Pentland
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products.

Authors:  K A Pritchard; P Y Wong; M B Stemerman
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

Review 6.  Heme oxygenase: the key to renal function regulation.

Authors:  Nader G Abraham; Jian Cao; David Sacerdoti; Xiaoying Li; George Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-01

7.  Hydroxy long-chain fatty acids in fungi.

Authors:  M S Van Dyk; J L Kock; A Botha
Journal:  World J Microbiol Biotechnol       Date:  1994-09       Impact factor: 3.312

8.  Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids.

Authors:  Houli Jiang; Fiona E Harrison; Kavita Jain; Samantha Benjamin; James M May; Joan P Graves; Darryl C Zeldin; John R Falck; Bruce D Hammock; John C McGiff
Journal:  Adv Biosci Biotechnol       Date:  2012-06-01

9.  CYP2J2 Expression in Adult Ventricular Myocytes Protects Against Reactive Oxygen Species Toxicity.

Authors:  Eric A Evangelista; Rozenn N Lemaitre; Nona Sotoodehnia; Sina A Gharib; Rheem A Totah
Journal:  Drug Metab Dispos       Date:  2018-01-17       Impact factor: 3.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.